- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: XL184 (CABOZANTINIB)
Total 277 results
-
Dana-Farber Cancer InstituteCompletedCarcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Massachusetts General HospitalCompletedLung Cancer | Solid Tumor (Not Breast or Prostate Cancers)United States
-
University of Michigan Rogel Cancer CenterExelixisTerminatedProstate Cancer MetastaticUnited States
-
Dana-Farber Cancer InstituteCompleted
-
ExelixisCompletedCancer | NSCLC | Solid TumorsJapan
-
Memorial Sloan Kettering Cancer CenterExelixisCompletedRelapsed or Refractory Multiple MyelomaUnited States
-
ExelixisCompletedHealthy | Hepatic ImpairmentUnited States
-
ExelixisCompletedHealthy | Renal ImpairmentUnited States
-
Dana-Farber Cancer InstituteExelixisTerminatedSkin Cancer | Merkel Cell CarcinomaUnited States
-
ExelixisActive, not recruitingMedullary Thyroid CancerAustralia, France, Israel, Spain, Russian Federation, Netherlands, Hungary, Korea, Republic of, Croatia, Italy, Canada, Poland, Romania, Sweden
-
Massachusetts General HospitalCompletedMultiple MyelomaUnited States
-
University of Alabama at BirminghamCompletedNeurofibromatosis | Plexiform Neurofibromas | NF1United States
-
Indiana UniversityTerminatedGlioblastoma Multiforme | High Grade Glioma | Anaplastic Astrocytoma | Malignant Brain TumorUnited States
-
ExelixisCompletedCancer | Solid TumorsUnited States, Taiwan, Belgium, Israel, United Kingdom
-
University of ChicagoNorthShore University HealthSystemCompletedRecurrent Prostate Cancer | Bone Metastases | Stage IV Prostate Cancer | Castrate-resistant Prostate CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI); Prostate Cancer FoundationTerminatedRecurrent Prostate Cancer | Castration-resistant Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingSoft Tissue Sarcoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Osteosarcoma | Ewing Sarcoma | Recurrent Renal Cell Carcinoma | Refractory Malignant Solid Neoplasm | Rhabdomyosarcoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Malignant Solid Neoplasm | Recurrent Osteosarcoma | Recurrent... and other conditionsUnited States
-
TakedaCompletedAdvanced Renal Cell CarcinomaJapan
-
Edwin Posadas, MDCompletedProstate CancerUnited States
-
TakedaCompletedAdvanced Hepatocellular CarcinomaJapan
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); ExelixisActive, not recruitingRenal Cell Carcinoma | Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8United States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Clear Cell AdenocarcinomaUnited States
-
ExelixisCompletedGlioblastoma MultiformeUnited States
-
ExelixisCompletedLymphoma | Cancer | Thyroid CarcinomaUnited States
-
ExelixisIpsenActive, not recruitingDifferentiated Thyroid CancerHong Kong, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Croatia, Czechia, France, Germany, Hungary, Israel, Korea, Republic of, Mexico, Netherlands, Poland, Romania, Russian Federation, Spain, Taiwan, ... and more
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Ewing Sarcoma | Recurrent Osteosarcoma | Stage III Osteosarcoma AJCC v7 | Stage IV Osteosarcoma AJCC v7 | Stage IVA Osteosarcoma AJCC v7 | Stage IVB Osteosarcoma AJCC v7 | Metastatic Osteosarcoma | Metastatic Ewing Sarcoma | Unresectable Ewing Sarcoma | Unresectable OsteosarcomaFrance
-
Massachusetts General HospitalCompletedProstate AdenocarcinomaUnited States
-
ExelixisCompletedHepatocellular CarcinomaBelgium, Hong Kong, Korea, Republic of, Canada, France, Taiwan, United States, Germany, Spain, United Kingdom, Singapore, Australia, Italy, Netherlands, Poland, Turkey, Ireland, New Zealand, Romania
-
ExelixisCompletedThyroid CancerFrance, United Kingdom, United States, Spain, Austria, Israel, Portugal, Saudi Arabia, Netherlands, Greece, Canada, Brazil, Chile, Poland, Italy, Russian Federation, Sweden, Germany, Denmark, India, Switzerland, Belgium, Korea, Republic... and more
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Adrenal Gland Pheochromocytoma | Locally Advanced Paraganglioma | Metastatic Paraganglioma | Unresectable Adrenal Gland Pheochromocytoma | Unresectable Paraganglioma | Regional Adrenal Gland PheochromocytomaUnited States
-
Baptist Health South FloridaExelixisRecruiting
-
University of Michigan Rogel Cancer CenterCompletedPancreatic CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingEndometrial Clear Cell Adenocarcinoma | Endometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Recurrent Uterine Corpus Cancer | Stage IV Uterine Corpus Cancer AJCC v7 | Stage IVA Uterine Corpus Cancer AJCC v7 | Stage IVB Uterine Corpus Cancer AJCC v7 | Endometrial Adenosquamous... and other conditionsUnited States, Canada
-
National Cancer Institute (NCI)CompletedRefractory Malignant Solid Neoplasm | Recurrent Melanoma | Recurrent Malignant Solid Neoplasm | Recurrent Thyroid Gland Carcinoma | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central Nervous System Neoplasm | Thyroid Gland Medullary CarcinomaUnited States, Canada
-
M.D. Anderson Cancer CenterExelixis; High Impact Clinical Research Support ProgramCompletedProstate CancerUnited States
-
Liza Villaruz, MDExelixisTerminatedNon Small Cell Lung Cancer (NSCLC) | Metastases to the BrainUnited States
-
Fundacion CRIS de Investigación para Vencer el...GlaxoSmithKline; Apices Soluciones S.L.; IpsenActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterExelixisRecruiting
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Neuroendocrine Neoplasm | Metastatic Neuroendocrine Carcinoma | Metastatic Large Cell Neuroendocrine Carcinoma | Metastatic Small Cell Neuroendocrine CarcinomaUnited States, Canada
-
National Cancer Institute (NCI)CompletedHIV Infection | Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Unresectable Solid NeoplasmUnited States
-
ExelixisCompletedRenal Cell CarcinomaUnited States, Belgium, Spain, Taiwan, Canada, Germany, Korea, Republic of, France, Austria, Chile, Australia, Hungary, Russian Federation, Italy, Turkey, Netherlands, Sweden, United Kingdom, Czechia, Ireland, Slovakia, Argentina, D... and more
-
Rennes University HospitalRecruitingBlood Concentrations of Nine Anti-cancer Drugs : Axitinib, Olaparib, regorafénib, Cabozantinib, Niraparib, Talazoparib, Palbociclib, Abemaciclib, TucatinibFrance
-
University of UtahExelixisActive, not recruitingBladder Cancer | Metastatic Urothelial CarcinomaUnited States
-
ExelixisActive, not recruitingRenal Cell CarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, Finland, France, Germany, Hong Kong, Hungary, Israel, Italy, Korea, Republic of, Mexico, Netherlands, New Zealand, Poland, Singapore, Spain, Taiwan, United...
-
ExelixisCompletedCarcinoma, Non-Small-Cell LungUnited States
-
Fox Chase Cancer CenterExelixisRecruitingMetastatic Renal Cell Carcinoma | Clear-cell Metastatic Renal Cell CarcinomaUnited States
-
ExelixisCompletedRenal Cell Carcinoma | Papillary Thyroid Cancer | Follicular Thyroid Cancer | Huerthle Cell Thyroid CancerUnited States
-
Istituto Oncologico Veneto IRCCSActive, not recruiting
-
National Cancer Institute (NCI)Active, not recruitingHIV Infection | Metastatic Renal Cell Carcinoma | Anatomic Stage III Breast Cancer AJCC v8 | Recurrent Ovarian Carcinoma | Metastatic Lung Non-Small Cell Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Melanoma | Recurrent Head and Neck Carcinoma | Recurrent Renal Cell Carcinoma | Advanced... and other conditionsUnited States
-
Mark SteinBristol-Myers Squibb; ExelixisRecruitingCYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition (Cyto-KIK)Kidney Cancer | Renal Cell CarcinomaUnited States